8,1 %In the pre-COVID-19 sample group (N = 283), the prevalence of antibody responders against RBD was 8.1% among females.
MaliSARS-CoV-2 RBDHAL · Unilimdocument de 67 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 197 evidences · page 18 / 48
8,1 %In the pre-COVID-19 sample group (N = 283), the prevalence of antibody responders against RBD was 8.1% among females.
MaliSARS-CoV-2 RBDHAL · Unilimdocument de 67 observations
10,7 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 10.7% showed a 10-fold increase in anti-CSP IgG antibody titres post-2019 as measured by GSK ELISA.
Burkina Faso · Malipaludismeobservé post-2019HAL · Unilimdocument de 105 observations
1,9 per_1000SMC was associated with a 1.9‰ reduction in malaria incidence in health districts with an adjusted coverage rate from 50.0% to 80.0%.
MalipaludismeHAL · Unilimdocument de 111 observations
24 %The clumping phenotype was observed in 24% of severe malaria isolates from Malian children.
Malipaludismepublié 2007The American journal of tropical medicine and hygieneeurope_pmcdocument de 3 observationsDOI 10.4269/ajtmh.2007.77.943
2,69 log10_copies/mLAmong high CMV virus shedders (>1000 copies/mL at day 0), the median viral load at day 14 was 2.69 log10 copies/mL in malaria cases treated with artemether-lumefantrine versus 3.08 log10 copies/mL in non-malaria comparisons.
Malicytomegalovirus (CMV)publié 2016Journal of clinical virology : the official publication of the Pan American Society for Cleurope_pmcdocument de 6 observations
91,8 %The median annual seasonal malaria chemoprevention (SMC) coverage rate increased from 91.8% in 2017–2018 to 95.0% in 2021–2022.
Malipaludismeobservé 2017–2018HAL · Unilimdocument de 111 observations
78,21 %The prevalence of normal haemoglobin (HbAA) among 3648 newborns in Mali was 78.21% (95% CI: 76.87–79.55).
Malinormal hemoglobinobservé April–August 2021HAL · Unilimdocument de 103 observations
53,5 msPour le variant rs1137617, la variation de l'intervalle QTc était de 53,5 ms (IC à 95 % : 2,5–93,5 ms) contre 13 ms (IC à 95 % : 8–27 ms) chez les témoins, mais cette différence n'était pas statistiquement significative (P = 0,11).
Malirs1137617HAL · Unilimdocument de 62 observations
400 childrenThe malaria vaccine candidate FMP2.1/AS02A was tested in a Phase 2 clinical trial in 400 Malian children randomized to 3 doses of the AMA1 vaccine candidate or control rabies vaccine on days 0, 30 and 60.
Malipaludismepublié 2016Vaccineeurope_pmcdocument de 2 observations
200 pf/microlThe cut-off value for pyrogenic threshold of Plasmodium falciparum parasitaemia was around 200 pf/microl during the dry season in Bandiagara district, Mali.
Malipaludismeobservé dry season of 1994publié 2005Tropical medicine & international health : TM & IHeurope_pmcdocument de 4 observationsDOI 10.1111/j.1365-3156.2005.01418.x
78 %L'extrait aqueux de racine de Cassia sieberiana a inhibé les crampes abdominales à hauteur de 78 % dans un test de torsion induite par l'acide acétique chez la souris à la dose de 300 mg/mL.
Malicrampes abdominalesHAL · Unilimdocument de 20 observations
Pre-treatment of red blood cells with neuraminidase, trypsin, and chymotrypsin caused a significant reduction in Plasmodium malariae invasion.
Malipaludismepublié 2025PLoS neglected tropical diseaseseurope_pmcdocument de 4 observations
10 health districtsIn 2021–2022, 10 health districts in the north and south of Mali did not receive seasonal malaria chemoprevention due to COVID-19-related shortages and insufficient resource mobilization by the Malian government.
Malipaludismeobservé 2021–2022HAL · Unilimdocument de 111 observations
5 400 parasites/μLLa parasitémie moyenne pour les infections à Plasmodium ovale chez les participants asymptomatiques était de 5 400 parasites/μL.
MalipaludismeHAL · Unilimdocument de 214 observations
96,1 %The diagnostic performance of SickleScan® for possible sickle cell disease (SCD) in Mali from April to August 2021 showed a sensitivity of 96.10% [95% CI: 94.75–97.45].
Malipossible sickle cell disease (SCD)observé April–August 2021HAL · Unilimdocument de 103 observations
6 311 casesFrom May 2024 to February 2025, 6,311 malaria cases were confirmed in the Kidal region.
Malipaludismeobservé May 2024 to February 2025HAL · Unilimdocument de 80 observations
39 %A significant proportion of participants believed that COVID-19 was a divine punishment (39%).
MaliCOVID-19HAL · Unilimdocument de 88 observations
6,8 %6.8% of individuals in the PIP profile strongly agreed that COVID-19 was a divine punishment.
MaliCOVID-19HAL · Unilimdocument de 88 observations
1 %Allele frequencies of K13-propeller mutations in sub-Saharan Africa ranged between 1% and 3%.
Malipaludismepublié 2015The Journal of infectious diseaseseurope_pmcdocument de 4 observations
60 %En 2018, seulement 60 % des cas de paludisme avaient été confirmés par microscopie optique au Mali.
Malipaludismeobservé 2018HAL · Unilimdocument de 214 observations
74,5 %After 3 years of seasonal malaria chemoprevention (SMC), the frequency of Pfdhps 437G mutation in Plasmodium falciparum was 74.5% compared to 64.6% at baseline in Ouelessebougou, Mali.
Malipaludismeobservé 2014-2016publié 2022Malaria journaleurope_pmcdocument de 7 observationsDOI 10.1186/s12936-022-04059-z
1 380 parasites/microlitreLa médiane du nombre de parasites de Plasmodium ovale par microlitre chez les 95 patients du groupe Kollé est de 1 380 (IQR : 1 020–1 740).
MalipaludismeHAL · Unilimdocument de 62 observations
65,2 %Le taux de prévalence du paludisme chez les personnes malades était de 65,2 % dans la localité étudiée.
MalipaludismeHAL · Unilimdocument de 214 observations
84 %About 84% of the population lived in high and moderate malaria transmission strata.
MalipaludismeHAL · Unilimdocument de 95 observations
30 daysPatients with stronger responses to S, RBD, or RBM experienced remission in a shorter time period (≤30 days).
MaliCOVID-19HAL · Unilimdocument de 67 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.